Christian Jaster (@JasterChris) header
Christian Jaster (@JasterChris) profile picture
Joined May 2021
Photo by Christian Jaster (@JasterChris)Photo by Christian Jaster (@JasterChris)Photo by Christian Jaster (@JasterChris)Photo by Christian Jaster (@JasterChris)Photo by Christian Jaster (@JasterChris)Photo by Christian Jaster (@JasterChris)Photo by Christian Jaster (@JasterChris)Photo by Christian Jaster (@JasterChris)Photo by Christian Jaster (@JasterChris)Photo by Christian Jaster (@JasterChris)
Aging is largely a glycine deficiency. Accumulation of methionine and methyl groups (via SAM) drive all of the main mechanisms of aging. Glycine reduces both of these. In fact, some models show that this pathway is required for the lifespan extending effects of calorie restriction. Glycine supplementation also increases lifespan in a number of organisms.
Glycine is one of the most powerful anti-aging tools in existence. It has lifespan extending properties (>28% in some) across several species. The main reason? It buffers excessive methyl groups from methionine, which can be highly damaging to health in the long run by promoting mTOR, insulin resistance and inflammation.
33
169
7
1,513
59,307
Christian Jaster retweeted
Aerobic training helps. Resistance training helps. The combo helps MORE. In a randomized trial of 196 overweight, sedentary adults, combining aerobic + resistance training improved insulin sensitivity more than either alone. (2015 RCT) Why the combination works: → Aerobic exercise improves your muscles’ ability to use glucose → Strength training builds and preserves glucose-hungry muscle → Both improve insulin action through partly different adaptations → Together, the benefits add up The 2026 ADA/EASD consensus recommends combining aerobic and resistance exercise for people with type 2 diabetes. You don’t need to become a runner or a bodybuilder. Walk. Lift. Repeat. Your muscles are one of your best tools for glucose control. Your move: add 2 strength sessions to your weekly walking routine. Do you currently do both—or mostly one? Source: AbouAssi H, et al. J Appl Physiol. 2015;118(12):1474–1482. #InsulinResistance
20
28
1
144
3,625
Christian Jaster retweeted
❌ Si a los 30 estás normal físicamente →a los 70 estarás mal. ⚠️ Si a los 40 estás bien físicamente → a los 70 llegarás justo. ✅ Solo si a los 30–40 estás EXCELENTE físicamente → llegarás funcional a los 70.
11
162
6
819
31,475
Christian Jaster retweeted
Regular exercise improves mental health (anxiety, depression, cognition). Improved cerebral oxygenation and mitochondrial function may be key mechanisms. Therapeutic mild hypoxia combined with exercise could enhance benefits, but evidence is limited. sciencedirect.com/science/ar…
27
1
87
1,928
Christian Jaster retweeted
People who live past 110 carry a strange immune cell: a helper T cell that acts like a killer. It makes up about 18% of their T cells, over 4 times the share seen in people in their 70s to 90s. And its receptors match ones found in lung tumors. A new Cell Reports study asks whether these cells help explain how they got there. Researchers from Keio University, RIKEN, and the University of Osaka profiled T cells from 28 Japanese donors: 8 in their 70s to 90s, 10 centenarians, and 10 supercentenarians (110 or older). They analyzed over 43,000 cells, tracking gene activity, surface proteins, and each cell's receptor. First, a quick primer on the immune cells involved. T cells are immune cells that patrol your body. CD4 T cells are usually helpers. They coordinate the immune response rather than kill anything directly. CD4 CTLs are an unusual subset that turn into killers, releasing toxic molecules like granzymes that destroy infected or abnormal cells. In most adults they're rare, under 5% of T cells. Every T cell carries a receptor that recognizes one specific target. Cells that share the same receptor are a clone. When a clone gets repeatedly stimulated by the same target, it multiplies. What they found: • CD4 killer cells rose with age. Median share of T cells was 4.0% in the 70s to 90s group, 9.6% in centenarians, and 17.6% in supercentenarians. • Helpers convert to killers in steps. Cells first lose a marker called CD27, then CD28. The in-between state (CD27 negative, CD28 positive) made up 10.5% of CD4 T cells, while the reverse order was under 0.3%. • The cells weren't worn out. They stayed negative for PD-1, a marker of exhaustion, and had low levels of other exhaustion genes. They look highly specialized, not depleted. • A few clones dominated. The single largest clone made up 33.3% of CD4 killer cells on average. In one centenarian, one clone was 126 of 234 cells. That pattern points to repeated stimulation by a persistent target. • The dominant clones were private. No two people shared the same top receptor, which suggests each person's cells were responding to their own targets. • One clone, many roles. After lab stimulation, cells from the same clone split into groups producing different signaling molecules, including types linked to antibody help, immune suppression, and allergic-type responses. All of them still made the inflammatory molecules IFN-gamma and TNF-alpha. Then the cancer angle. The authors searched a database of over 690 million receptor sequences. Of the top clones that matched, 32 of the 36 expanded matches came from cancer patients, mostly lung cancer (17). But none of the supercentenarians or centenarians had a history of lung, breast, or liver cancer. The team suggest these cells may be responding to something subclinical, such as early abnormal cells, senescent cells, or reactivated latent viruses. Earlier work showed CD4 killer cells can clear senescent cells in aged skin and suppress tumors in mouse models. Some very important limits here: Only 28 people were studied, and the cells came from blood, not tissues, so we don't know what they actually target. This study didn't test whether these cells kill cancer cells. The database matches rest on one receptor chain and show overlap, not proof of the same target. The cytokine results come from lab stimulation. The authors also note these cells cut both ways. In other settings, they're linked to autoimmune disease, cardiovascular disease, and excess inflammation. Whether they help or harm may depend on how well inflammation is kept in check. Still, it points to a possible feature of aging well: an immune system that shifts from broad coverage toward focusing on the threats it has already learned to recognize. For longevity, the idea that immune aging is only decline may be too simple. These cells looked specialized, not exhausted. But these are people who already reached 110, so it's unclear whether the cells helped them get there or simply reflect an immune system that aged well. That second point is my inference, not something the study tested. Immune function at 100 likely reflects decades of exposures, inflammation, and repair, and how well those were managed from midlife on.
6
22
1
127
4,398
Christian Jaster retweeted
We've been calling it mitochondrial dysfunction for decades. Turns out that term is scientifically meaningless, and it's been holding back progress in understanding how mitochondria actually work. @MitoPsychoBio and colleagues published a perspective in Nature Metabolism arguing that the language mitochondrial scientists use fails to capture what mitochondria actually are: multifunctional organelles that dynamically recalibrate across dozens of independent activities depending on what cells need. The problem starts with oversimplification. Mitochondria get reduced to the powerhouse of the cell in introductory biology. That framing suggests a single primary job: make ATP. Reality is more complex. Mitochondria synthesize steroid hormones. They produce iron-sulfur clusters required for hundreds of proteins throughout the cell. They regulate innate immunity and antiviral responses. They control programmed cell death. They generate signaling molecules that reprogram nuclear gene expression. They can transfer between cells to rescue damaged tissue. Key insight: These aren't backup functions that kick in when energy production fails. They're simultaneous, independent, cell-type-specific roles that mitochondria perform constantly. Here's why the terminology matters: When researchers measure decreased ATP production and call it mitochondrial dysfunction, they're collapsing dozens of distinct mitochondrial activities into a binary working/broken framework. That creates problems: • A mitochondrion producing less ATP might be signaling rather than failing • Different mitochondrial activities can change independently • What looks dysfunctional in one context may be adaptive in another • Cell-type differences get lost when using generic terms The paper proposes a hierarchical terminology system with five levels: 1. Cell-dependent properties: Mitochondrial characteristics that vary by cell type. Neurons, muscle cells, and immune cells contain functionally distinct mitochondrial populations adapted to tissue-specific demands. 2. Molecular features: The structural and compositional elements. Membrane potential, protein composition, lipid content, mtDNA copy number, cristae architecture. 3. Activities: Specific biochemical processes. Oxygen consumption, ATP synthesis, reactive oxygen species production, calcium buffering, metabolite synthesis. 4. Functions: The biological purposes these activities serve. Energy provision, biosynthesis, signaling, quality control, cell death regulation. 5. Behaviors: Dynamic responses over time. Fusion, fission, movement, mitophagy, biogenesis, transfer between cells. The framework distinguishes what mitochondria are made of, what they do biochemically, why they do it biologically, and how they change over time. Example of how this improves precision: Old framing: This drug causes mitochondrial dysfunction. New framing: This drug decreases complex I activity, reducing ATP synthesis capacity while increasing superoxide production at complex III, without affecting calcium handling or steroid synthesis. The second version identifies which specific mitochondrial activities change and which remain intact. That matters for predicting side effects, understanding mechanisms, and designing interventions. The malleable nature of mitochondria creates additional complexity. Mitochondrial characteristics can shift within minutes to hours in response to nutrient availability, stress, or signaling molecules. These recalibrations are often reversible and physiologically appropriate. Calling a physiological recalibration dysfunction conflates adaptation with pathology. A muscle cell's mitochondria after endurance training look different from before training. Neither state is dysfunctional. They're optimized for different demands. The perspective argues this terminology shift will improve three outcomes: Teaching: Students learn mitochondria are multifaceted organelles rather than single-purpose powerhouses, building a more accurate mental model from the start. Research progress: Specific terminology forces specific measurements. Asking which mitochondrial activities change rather than whether mitochondria are dysfunctional leads to more mechanistic studies. Interdisciplinary collaboration: Clearer language helps researchers from different fields understand exactly what aspects of mitochondrial biology are relevant to their questions. The implications extend beyond semantics. How scientists conceptualize mitochondria shapes which questions get asked, which measurements get prioritized, and how findings get interpreted. Moving from function/dysfunction binary to multidimensional assessment requires more complex experimental designs. But that complexity better matches the biological reality. Mitochondria aren't failing when they recalibrate. They're responding. Understanding which specific activities change, in which cells, under which conditions, and with what biological purpose represents the path forward for mitochondrial science.
12
81
7
416
15,957
Christian Jaster retweeted
severe depression reversed in under 7 days when patients took 125-300 mg of magnesium glycinate with meals and at bedtime.
Readers added context they thought people might want to know
The studies in the post do not support the claim. The 2006 paper presents case histories (not a controlled trial) using magnesium glycinate and taurinate; the 2017 trial used magnesium chloride over 6 weeks for mild-to-moderate depression. gwern.net/doc/nootropic/… pmc.ncbi.nlm.nih.gov/articles/PMC54… pmc.ncbi.nlm.nih.gov/articles/PMC10…
100
697
157
12,599
541,851
Christian Jaster retweeted
You train to protect your mitochondria from aging. And it works. Exercise preserves mitochondrial energy production into your 90s. But a 2025 study by @GGouspillou and colleagues reveals there's a second mitochondrial function that declines with age no matter how much you exercise. Gouspillou and his colleagues at Université du Québec à Montréal divided 139 men aged 20 to 93 into active and inactive groups. They measured physical performance, muscle composition, and three critical mitochondrial functions: energy production, free radical generation, and calcium handling capacity. The conventional wisdom says mitochondria wear out with age, becoming a leaky metabolic engine that produces more oxidative stress and becomes less capable of taking nutrients and converting them into ATP. Direct measurement across 73 years of aging shows that's not necessarily correct. Mitochondrial energy production stayed completely stable in active participants from their 20s through their 90s. A 90-year-old who stayed active had mitochondria that produced energy like a 20-year-old. Inactive individuals showed declining energy production, but it tracked with how little they moved, not how many years they'd lived. When normalized to mitochondrial content, the differences disappeared entirely. The study suggests that aging doesn't break energy production. Physical inactivity reduces how many mitochondria you maintain. Each individual mitochondrion works just as well at 90 as at 20. Free radical production, blamed for decades as an aging driver, showed no increase with age. Active participants actually produced more free radicals than inactive individuals while displaying superior strength and performance. The free radical theory of muscle aging didn't hold. The study had some interesting headlines: • Physical activity protects performance across the lifespan but doesn't completely prevent age-related decline • Mitochondrial energy production depends on activity level, not chronological age • Free radical production remains stable with aging and reflects mitochondrial health, not damage • Mitochondrial calcium handling capacity drops sharply after age 60 in both active and inactive individuals • Reduced calcium handling correlates with lower muscle mass, strength, and performance • Deterioration accelerates dramatically after 60 rather than declining gradually The calcium handling finding represents the first mitochondrial function that deteriorates with aging regardless of exercise. Mitochondria normally act as calcium buffers, absorbing excess calcium to keep cells functioning properly. When this buffering capacity fails, a protective channel called the permeability transition pore opens too easily. Think of it like a circuit breaker that's supposed to trip only during emergencies but starts tripping at lower and lower thresholds. When the pore opens prematurely, stored calcium floods back into the cell, triggering a cascade of damage. This calcium release activates pathways that break down muscle protein faster than the body builds it back up. It generates bursts of oxidative stress that damage cellular components. It releases mitochondrial DNA that the immune system mistakes for bacterial invasion, triggering inflammation. Each pathway drives muscle loss without requiring energy failure. The mitochondria still produce ATP normally. They've just lost the ability to prevent calcium from activating destructive programs that eat away at muscle tissue. The study measured calcium handling by exposing muscle mitochondria to calcium loads and tracking retention. Both active and inactive participants showed declining capacity, but the pattern matters. Calcium handling remained relatively stable from ages 20 to 60, then dropped sharply after 70. Calcium retention capacity correlated with thigh muscle mass, knee strength, walking distance, and mobility performance. It also correlated with GDF15, a stress molecule that rises with aging and predicts worse health outcomes. This suggests calcium handling directly influences muscle health and systemic aging markers. Physical activity protected functional performance. Active participants outperformed inactive individuals on strength and mobility tests across all age groups. But both groups showed age-related declines. Exercise delays deterioration but doesn't eliminate it. Muscle fiber composition revealed how activity and aging affect muscle differently. Active young adults had more type I endurance fibers that stayed stable across decades. Inactive individuals showed fiber type changes suggesting nerve disconnection from muscle that active individuals avoided. Intermuscular fat, the marbling that accumulates in muscle tissue, increased with aging in both groups. But physical activity provided protection in later decades. Older active individuals had less fat infiltration than older inactive individuals, though the protective effect only emerged after years of consistent activity. The implications challenge decades of research direction. Drug development targeting mitochondrial energy production in aging muscle produced zero effective treatments. This study suggests those efforts addressed the wrong problem. Energy production itself doesn't decline with healthy aging. Calcium handling deterioration appears to be the actual mechanism driving muscle loss. Restoring calcium buffering capacity or preventing the permeability transition pore from opening prematurely may represent more effective intervention points than trying to boost energy production or mitochondrial numbers. There are some limitations that stand out when you read the paper: First, only men participated. So findings may not apply equally to women. Participants were relatively healthy community-dwelling adults, not people with severe muscle wasting. The design prevents establishing whether calcium handling failure causes muscle loss or just accompanies it. With that being said, the data fundamentally reframe what aging does to muscle. Energy failure on per mitochondria level isn't the driver in healthy aging. Inactivity reduces mitochondrial numbers while aging leaves energy production intact. The exception, calcium handling deterioration occurring regardless of activity, appears to be where aging actually operates.
25
78
8
380
20,232
Christian Jaster retweeted
Creatine is known for building muscle and improving athletic performance. A new UCLA study just found it does something completely different: it powers the immune cells that direct your body's cancer-fighting response. Researchers at UCLA published findings in iScience showing creatine supplementation enhances dendritic cell function and suppresses tumor growth in preclinical models. The work identifies a metabolic bottleneck in cancer immunity and suggests creatine might help address it. What dendritic cells do Dendritic cells serve as coordinators of your immune system's response to cancer. They patrol tissues, capture pieces of tumor cells, and present those fragments to T cells in lymph nodes. This presentation activates T cells to recognize and attack cancer. Without functional dendritic cells, T cells never get properly instructed. The immune system fails to mount an organized response against tumors. Patients with more dendritic cells in their tumors tend to have better outcomes and more active immune responses. There is an energy problem in dysfunctional dendritic cells. Dendritic cells require significant energy to function. When they encounter danger signals from tumors, they activate, migrating to lymph nodes, ramping up production of surface molecules that interact with T cells, and secreting inflammatory signals. All of this requires ATP, the cellular energy currency. Inside tumors, dendritic cells face a hostile metabolic environment. Cancer cells consume available glucose and other nutrients aggressively. Immune cells competing for those same resources often lose out, leaving them energy-depleted and dysfunctional. Where does creatine fit in? Creatine functions as an energy buffer. Inside cells, an enzyme called creatine kinase adds a phosphate group to creatine, creating phosphocreatine. When ATP gets consumed during cellular work, phosphocreatine rapidly donates its phosphate back to regenerate ATP. This system is particularly important in tissues with high, fluctuating energy demands like muscle and brain. Athletes supplement with creatine to maintain ATP availability during intense exercise. The researchers found dendritic cells also rely on this system. When activated, dendritic cells dramatically upregulate expression of the creatine transporter, the protein that imports creatine into cells. Intratumoral dendritic cells showed especially high transporter levels compared to dendritic cells from spleens. So how did the team test their hypothesis? The team used two complementary approaches. First, they generated mice lacking the creatine transporter specifically in immune cells. Dendritic cells from these knockout mice showed impaired survival and activation when stimulated. They expressed lower levels of costimulatory molecules needed to activate T cells and produced fewer inflammatory cytokines. When these creatine-deficient dendritic cells were co-cultured with T cells, the T cells proliferated less, produced fewer effector molecules, and showed reduced activation markers. The dendritic cells couldn't effectively prime an immune response. Second, the researchers tested whether creatine supplementation could enhance normal dendritic cell function. Adding creatine to cell cultures improved dendritic cell survival and ramped up their activation. The cells displayed more surface proteins that signal readiness to interact with T cells and pumped out higher levels of inflammatory signaling molecules that coordinate immune responses. There were some interesting mechanistic findings as well. RNA sequencing revealed creatine supplementation activated energy-dependent inflammatory signaling pathways in dendritic cells. Metabolic profiling showed creatine-treated cells maintained higher ATP levels and increased phosphocreatine stores. The researchers directly measured ATP in dendritic cells. Cells lacking the creatine transporter showed significantly lower ATP levels after activation compared to normal cells. Creatine supplementation restored and even enhanced ATP availability. This ATP preservation appears critical for dendritic cell function. Many of the processes required for activation, including protein synthesis, trafficking of molecules to the cell surface, and cytokine secretion, are energy-intensive. When ATP drops, these functions fail. The tumor experiments were particularly fascinating. The team tested whether creatine supplementation could enhance anti-tumor immunity in mice bearing B16 melanoma tumors, an aggressive cancer model. Mice received either regular drinking water or water supplemented with creatine. Creatine-supplemented mice showed significantly slower tumor growth. Analysis of the tumor tissue revealed more activated dendritic cells with higher expression of maturation markers. These tumors also contained more activated T cells producing IFN-γ, a key anti-tumor cytokine. Importantly, the anti-tumor effect of creatine required functional dendritic cells. When the researchers depleted dendritic cells, creatine supplementation no longer suppressed tumor growth. This confirmed dendritic cells were the critical cell type mediating creatine's effects. Human relevance The researchers tested whether their findings applied to human cells. They generated dendritic cells from human blood monocytes and treated them with creatine. Human dendritic cells responded similarly to mouse cells: enhanced activation, increased costimulatory molecule expression, and improved capacity to stimulate T cell responses. This cross-species validation strengthens the translational potential. The creatine transporter and creatine kinase system are evolutionarily conserved between mice and humans. Key takeaways: • Dendritic cells upregulate creatine transporter expression when activated, especially in tumor environments • Creatine functions as an ATP buffer, maintaining energy availability during dendritic cell activation • Knockout of creatine transporter impairs dendritic cell survival, activation, and ability to prime T cell responses • Creatine supplementation enhances dendritic cell function in both mouse and human cells • Oral creatine supplementation suppressed melanoma tumor growth in mice through dendritic cell-dependent mechanisms • The effect was mediated by improved dendritic cell ATP levels and enhanced inflammatory signaling It's a super fascinating study for what it tells us about the role of creatine outside of musculoskeletal function. There are some limitations, however. The tumor experiments used a single cancer type in young, healthy mice. Whether creatine supplementation works across different tumor types, in aged mice, or in the context of existing immunotherapies remains untested. The creatine doses used in mouse drinking water translate to relatively high human equivalent doses, though still within the range commonly used by athletes (typically 3-5 grams per day). The study measured associations between creatine treatment and immune activation but didn't fully map all downstream mechanisms. Additional signaling pathways likely contribute. All experiments used syngeneic tumor models where mice develop cancer from transplanted tumor cells. Spontaneous tumor models or patient samples would provide additional validation. This work adds to emerging evidence that creatine plays immunomodulatory roles beyond its established effects on muscle and brain. Previous studies from other groups showed creatine enhances CD8 T cell function and polarizes tumor-associated macrophages toward anti-tumor phenotypes. The convergence across multiple immune cell types suggests creatine metabolism represents a general mechanism supporting anti-tumor immunity in metabolically challenging tumor environments. Dendritic cells represent a logical target for metabolic interventions. They're relatively rare in tumors but have outsized influence on whether productive immune responses develop. Enhancing their function could amplify downstream T cell responses. Current cancer immunotherapies focus heavily on T cells, particularly checkpoint inhibitors that release brakes on T cell activity. But those therapies depend on T cells already being properly activated. If dendritic cells fail at the initial priming step, checkpoint inhibitors have less to work with. Metabolic support for dendritic cells could complement T cell-directed therapies. The combination might prove especially valuable in immunologically cold tumors that lack robust immune infiltration. The practical advantage of creatine is accessibility. It's inexpensive, widely available, well-tolerated at typical doses, and has decades of safety data from use in athletes. The safety profile makes it a reasonable candidate for clinical testing. The next step is human trials examining whether creatine supplementation enhances immune responses in cancer patients, particularly those receiving immunotherapy. Endpoints would include dendritic cell activation markers in blood and tumors, T cell responses to tumor antigens, and clinical outcomes. The study provides proof of concept that targeting dendritic cell metabolism can enhance anti-tumor immunity and identifies creatine as a specific intervention worthy of further investigation.
7
42
10
253
36,154
Christian Jaster retweeted
其实再过几年,大家就会明白。工作不重要,结婚生子不重要,努力也不重要。很多被世俗奉为人生大事的东西,到头来不过是徒有虚名。因为大家终究要回到生命本身。 你要睡得安稳,身体要健康,活的要轻松、自在、从容。没有必要为了满足别人的期待,消耗自己身体。那些社会标榜的成功标准,都对你的幸福毫无帮助。 如果说人生一定要追寻什么的话,那一定是在照顾好身体的基础上,找到一种真正符合内心意愿的生活方式。毕竟,人生只是为了体验生命本身。
130
740
37
4,850
159,127
Christian Jaster retweeted
Walking to motivating music increased exercise by 15%
listening to music while exercising is one of life's greatest joys
84
66
7
1,717
81,017
Christian Jaster retweeted
How to actually remember what you read: - Read the material once - book, chapter, research article, doesn't matter - Step away from it. Walk, close your eyes, leave them open - Try to replicate the information from scratch, as if teaching a class without your notes - Go back to the material, check what you missed, make a note - Highlighting and underlining are motor commands. They bring you back to a page, they don't build the memory - Expect it to be mentally taxing. That's the tradeoff - it's fast and you don't forget Dr. Cal Newport on @hubermanlab
8
90
6
1,069
29,038
体をよく動かしている人ほど幸福感が高く、その背景の半分近くには「自分はできる」という自己効力感があったというFront Psycholの研究報告。
3
21
2
134
6,097
Christian Jaster retweeted
Most exercise and aging studies can't answer a basic question: is muscle deterioration from aging itself, or just from decades of moving less? A new Nature Aging study solved this by recruiting older adults who moved as much as people in their twenties. The researchers from Amsterdam UMC and Maastricht University recruited four distinct groups: young adults in their twenties, older adults whose daily step counts and high-intensity activity matched the young group, older adults who had trained consistently for years (three structured hour-long sessions per week for over a year), and older adults with early physical impairment. They took muscle biopsies before and after a one-hour cycling session, then measured over 24,000 gene transcripts, 135 metabolites, and 1,383 lipid species. By matching activity levels between young and older groups, any molecular differences couldn't be blamed on the older adults simply moving less. This isolated aging from inactivity for the first time at this molecular depth. Key findings: • The defining molecular signature of muscle aging is an energy crisis. Comparing young adults to activity-matched older adults, 1,106 genes were downregulated with age. These genes build the mitochondrial machinery that produces cellular energy: ATP synthase, cytochrome c oxidase, and NADH dehydrogenase subunits. Mitochondria are the power plants of cells, converting nutrients into ATP, the energy currency cells use to function. When these genes decline, cells lose their ability to generate energy efficiently. • NAD+ levels declined and triglycerides accumulated inside aging muscle. NAD+ is a molecule required for energy production and cellular repair. Lower NAD+ means less capacity to convert fuel into usable energy. Triglycerides are stored fats, their accumulation inside muscle indicates unburned fuel piling up as the tissue loses its ability to process it. • More than half the molecular signature of muscle aging was absent in trained older adults. Specifically, 57.1% of age-related gene downregulation and 55.9% of upregulation were missing in the trained group. Their muscle resembled young adults far more than their chronological age would predict. • The changes training preserved were specifically the energy metabolism ones. Genes like NDUFS1 and COX5A, which were depleted in normally active and impaired older adults, sat at youthful levels in the trained group across all five mitochondrial respiratory complexes. The single most prominent feature of muscle aging turned out to be the single most preventable. • Being generally active was not enough. Structured training was the difference. The normally active older adults walked as much as young adults, and their energy metabolism genes declined anyway. What preserved the youthful molecular profile was structured, sustained training. Filling a step counter and being genuinely trained are not equivalent at the molecular level. • Roughly half of muscle aging persisted regardless of training. Changes in genes controlling synaptic transmission (how nerves communicate with muscle) and WNT signaling (a pathway regulating tissue maintenance and stem cell function) appeared in all older adults, trained or not. This unavoidable half is where drugs will have to work. • The fittest muscle mounted the largest inflammatory response to exercise. All groups activated stress and immune genes after exercise, including IL6, IL1B, and TNF. But the magnitude scaled with fitness. Trained older adults most closely resembled young adults in their response, followed by normally active, with impaired older adults showing the most blunted response. The stress response to exercise appears to be the mechanism of adaptation, not damage to be minimized. This raises a concern about anti-inflammatory longevity strategies. If the inflammatory stress response is how exercise produces its benefits, chronically suppressing inflammation may blunt the adaptation that exercise depends on. It doesn't mean inflammation is beneficial in general, but the timing and context matter. A separate discovery: the proteasome appears to regulate NAD+. The proteasome is the cellular machinery that breaks down damaged proteins. When researchers inhibited it, NAD+ levels rose in both muscle and liver cells to a degree comparable to NAD+ precursor supplements. This opens a new route to understanding NAD+ decline that operates through protein turnover rather than just supplying more raw material. The study draws a clear line between what lifestyle can address and what will require therapeutics. The energy metabolism decline, mitochondrial deterioration, and NAD+ depletion that define muscle aging are largely preventable through structured training. The synaptic and signaling changes that persist in all older adults represent the unavoidable half where drugs will need to work. The decisions made about structured training in midlife determine which molecular trajectory muscle follows in later decades. Half of muscle aging is optional. The other half isn't. Knowing which changes belong to each category is knowing where behavior ends and biology takes over.
40
148
23
843
86,369
Christian Jaster retweeted
Las personas que durante 1 mes hicieron ayuno intermitente, comiendo sólo de 8:00 a 16:00, redujeron su edad cerebral 9 meses. Se detectó en resonancia magnética, pero además mejoraron un 19% en pruebas de memoria. También hubo mejoras en insulina, triglicéridos, peso...
15
186
10
1,201
31,698